Small molecule · Inhibitor of Werner syndrome ATP-dependent helicase (WRN)
Phase 1/2Most advanced trial
1Registered trials
What is GSK4418959?
GSK4418959 is an orally bioavailable inhibitor of the Werner syndrome ATP-dependent helicase (WRN), a multifunctional enzyme with helicase and exonuclease activities involved in DNA replication and repair. It is being studied in solid tumors, including colorectal, colon, rectal and endometrial cancers.
Summary written with AI from the sources listed at the end of this page.
At a glance
Drug type
Small molecule
Targets
Werner syndrome ATP-dependent helicase (WRN)
Mechanism
Inhibitor of Werner syndrome ATP-dependent helicase (WRN)
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.